BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17872347)

  • 21. ACTH-producing remnants following apoplexy of an ACTH-secreting pituitary macroadenoma.
    Messer CK; Fowkes ME; Gabrilove JL; Post KD; Son H; Levine AC
    Pituitary; 2012 Dec; 15 Suppl 1():S6-9. PubMed ID: 20703943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinically Silent Adrenocorticotropic Hormone-Positive Crooke Cell Adenoma: Case Report and Review of Literature.
    Todnem N; Ward A; Segar S; Rojiani AM; Rahimi SY
    World Neurosurg; 2018 Nov; 119():197-200. PubMed ID: 30077745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An aberrant ACTH-producing ectopic pituitary adenoma in the sphenoid sinus.
    Suzuki J; Otsuka F; Ogura T; Kishida M; Takeda M; Tamiya T; Nishioka T; Tanaka Y; Hashimoto K; Makino H
    Endocr J; 2004 Feb; 51(1):97-103. PubMed ID: 15004415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful reduction of ACTH secretion in a case of intractable Cushing's disease with pituitary Crooke's cell adenoma by combined modality therapy including temozolomide.
    Tanaka S; Yamamoto M; Morita M; Takeno A; Kanazawa I; Yamaguchi T; Yamada S; Inoshita N; Oki Y; Kurosaki M; Sugimoto T
    Endocr J; 2019 Aug; 66(8):701-708. PubMed ID: 31130573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First Report of Coexistence of Two Ectopic Pituitary Tumors: Rathke Cleft Cyst and Silent Adrenocorticotropic Hormone Adenoma.
    Pojskić M; Zbytek B; Beckford NS; Boop FA; Arnautović KI
    World Neurosurg; 2017 Aug; 104():1048.e1-1048.e7. PubMed ID: 28532906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galectin-3 Expression in Functioning and Silent ACTH-Producing Adenomas.
    Jin L; Riss D; Ruebel K; Kajita S; Scheithauer BW; Horvath E; Kovacs K; Lloyd RV
    Endocr Pathol; 2005; 16(2):107-14. PubMed ID: 16199895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of ACTH-secreting supradiaphragmatic adenomas.
    Dam-Hieu P; Irthum B; Seizeur R; Roudaut N; Besson G
    Clin Neurol Neurosurg; 2007 Oct; 109(8):698-704. PubMed ID: 17532556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary apoplexy in an adrenocorticotropin-producing pituitary macroadenoma.
    Sahin SB; Cetinkalp S; Erdogan M; Cavdar U; Duygulu G; Saygili F; Yilmaz C; Ozgen AG
    Endocrine; 2010 Oct; 38(2):143-6. PubMed ID: 21046475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pituitary atypical adenoma or malignant corticotrophinoma?].
    Alves M; Paiva I; Belo F; Rebelo O; Bastos M; Carvalheiro M
    Acta Med Port; 2011 Dec; 24 Suppl 3():661-6. PubMed ID: 22856408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nelson Syndrome: Clival Invasion of Corticotroph Pituitary Adenoma Resulting in Alternating Sixth Nerve Palsies.
    Douglas VP; Douglas KAA; Rapalino O; Champion SN; Chwalisz BK
    J Neuroophthalmol; 2021 Mar; 41(1):114-118. PubMed ID: 33394640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ectopic Adrenocorticotropic Hormone-Secreting Pituitary Adenomas: An Underestimated Entity.
    Knappe UJ; Jaspers C; Buschsieweke D; Reinbold WD; Alomari A; Saeger W; Ehlenz K; Mann WA; Kann PH; Feldkamp J
    Neurosurgery; 2017 Apr; 80(4):525-533. PubMed ID: 27352274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas.
    Cannavò S; Almoto B; Dall'Asta C; Corsello S; Lovicu RM; De Menis E; Trimarchi F; Ambrosi B
    Eur J Endocrinol; 2003 Sep; 149(3):195-200. PubMed ID: 12943521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical behaviour of an incidentally diagnosed silent corticotroph adenoma.
    Benaiges D; Puig J; Lafuente J; Gimeno J; Prados M; Sagarra E; Flores-Le-Roux J
    Neuro Endocrinol Lett; 2012; 33(3):290-3. PubMed ID: 22635086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of corticotroph carcinoma that caused multiple cranial nerve palsies, destructive petrosal bone invasion, and liver metastasis.
    Ono M; Miki N; Amano K; Hayashi M; Kawamata T; Seki T; Takano K; Katagiri S; Yamamoto M; Nishikawa T; Kubo O; Sano T; Hori T; Okada Y
    Endocr Pathol; 2011 Mar; 22(1):10-7. PubMed ID: 21234708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and treatment of pituitary adenomas.
    Chanson P; Salenave S
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silent or Subclinical Corticotroph Pituitary Macroadenoma Transforming Into Cushing Disease: 11-Year Follow-up.
    Melcescu E; Gannon AW; Parent AD; Fratkin JF; Nicholas WC; Koch CA; Galhom A
    Neurosurgery; 2013 Jan; 72(1):E144-6. PubMed ID: 23037824
    [No Abstract]   [Full Text] [Related]  

  • 37. The coexistence of infundibular pituicytoma and Cushing's disease due to pituitary adenoma: A case report.
    Gezer E; Selek A; Cetinarslan B; Canturk Z; Tarkun I; Ceylan S
    Endocr Regul; 2019 Oct; 53(4):263-267. PubMed ID: 31734654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical type II silent corticotrophic adenoma developing into Cushing's disease upon second recurrence.
    Psaras T; Honegger J; Buslei R; Saeger W; Klein D; Capper D; Meyermann R; Mittelbronn M
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):610-5. PubMed ID: 17943697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consensus-driven in-hospital cortisol assessment after ACTH-secreting pituitary adenoma resection.
    Stolyarov Y; Mirocha J; Mamelak AN; Ben-Shlomo A
    Pituitary; 2018 Feb; 21(1):41-49. PubMed ID: 29143885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of tissue-based ACTH-antibody assay-guided transsphenoidal resection of pituitary adenomas in Cushing disease.
    Erfe JM; Perry A; McClaskey J; Inzucchi SE; James WS; Eid T; Bronen RA; Mahajan A; Huttner A; Santos F; Spencer D
    J Neurosurg; 2018 Sep; 129(3):629-641. PubMed ID: 29027854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.